Enzo Biochem: Hamid Erfanian, Kara Cannon

Hamid Erfanian has resigned as CEO and director of Enzo Biochem, effective Sept. 5. He had led the company since 2021, overseeing the divestiture of Enzo Clinical Lab to Labcorp earlier this year. No reasons for his departure were provided.  Previously, Erfanian was chief commercial officer at PerkinElmer's Euroimmun. Kara Cannon, Enzo's chief operating officer, is assuming the role of interim CEO.